Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Jan 30;13(3):793.
doi: 10.3390/jcm13030793.

Diabetic Kidney Disease in Post-Kidney Transplant Patients

Ngoc-Yen T Pham  1 , Diego Cruz  2 , Luis Madera-Marin  1 , Raja Ravender  1 , Pablo Garcia  1
Affiliations
Review

Diabetic Kidney Disease in Post-Kidney Transplant Patients

Ngoc-Yen T Pham et al. J Clin Med. .

Abstract

Post-transplant diabetes mellitus (PTDM) is a common occurrence in post-kidney transplantation and is associated with greater mortality, allograft failure, and increased risk of infections. The primary goal in the management of PTDM is to achieve glycemic control to minimize the risk of complications while balancing the need for immunosuppression to maintain the health of the transplanted kidney. This review summarizes the effects of maintenance immunosuppression and therapeutic options among kidney transplant recipients. Patients with PTDM are at increased risk of diabetic kidney disease development; therefore, in this review, we focus on evidence supporting the use of novel antidiabetic agents and discuss their benefits and potential side effects in detail.

Keywords: PTDM; diabetes; diabetic nephropathy; kidney transplant.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
The pillars of PTDM care. Lifestyle modification must be implemented even prior to transplantation; insulin therapy in the early post-transplant period, GLP-1 agonist could be initiated in the outpatient setting early post-transplant and SGLT-2 inhibitors once a baseline creatinine has been established and there are no concerns for urinary tract infections.
See this image and copyright information in PMC

References

    1. Hariharan S., Johnson C.P., Bresnahan B.A., Taranto S.E., McIntosh M.J., Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N. Engl. J. Med. 2000;342:605–612. doi: 10.1056/NEJM200003023420901. - DOI - PubMed
    1. Port F.K., Wolfe R.A., Mauger E.A., Berling D.P., Jiang K. Comparison of survival probabilities for dialysis patients vs. cadaveric renal transplant recipients. JAMA. 1993;270:1339–1343. doi: 10.1001/jama.1993.03510110079036. - DOI - PubMed
    1. Ojo A.O., Port F.K., Wolfe R.A., Mauger E.A., Williams L., Berling D.P. Comparative mortality risks of chronic dialysis and cadaveric transplantation in black end-stage renal disease patients. Am. J. Kidney Dis. 1994;24:59–64. doi: 10.1016/S0272-6386(12)80160-0. - DOI - PubMed
    1. Alangaden G.J., Thyagarajan R., Gruber S.A., Morawski K., Garnick J., El-Amm J.M., West M.S., Sillix D.H., Chandrasekar P.H., Haririan A. Infectious complications after kidney transplantation: Current epidemiology and associated risk factors. Clin. Transplant. 2006;20:401–409. doi: 10.1111/j.1399-0012.2006.00519.x. - DOI - PubMed
    1. Engels E.A., Pfeiffer R.M., Fraumeni J.F., Jr., Kasiske B.L., Israni A.K., Snyder J.J., Wolfe R.A., Goodrich N.P., Bayakly A.R., Clarke C.A., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA. 2011;306:1891–1901. doi: 10.1001/jama.2011.1592. - DOI - PMC - PubMed

LinkOut - more resources